nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An in vivo duck hepatitis B virus model recapitulates key aspects of nucleic acid polymer treatment outcomes in chronic hepatitis B patients
|
Debing, Yannick |
|
|
224 |
C |
p. |
artikel |
2 |
Editorial Board
|
|
|
|
224 |
C |
p. |
artikel |
3 |
Mechanism of action of phthalazinone derivatives against rabies virus
|
Perraud, Victoire |
|
|
224 |
C |
p. |
artikel |
4 |
Methyl rosmarinate is an allosteric inhibitor of SARS-CoV-2 3 CL protease as a potential candidate against SARS-cov-2 infection
|
Li, Hongtao |
|
|
224 |
C |
p. |
artikel |
5 |
Neutralizing antibodies to block viral entry and for identification of entry inhibitors
|
Tam, Ee Hong |
|
|
224 |
C |
p. |
artikel |
6 |
Prophylactic effect of ensitrelvir in mice infected with SARS-CoV-2
|
Nobori, Haruaki |
|
|
224 |
C |
p. |
artikel |
7 |
SARS-CoV-2 virus-like particle variants alpha and delta mimic the native viruses in their differential inflammasome activating potential
|
Bandyszewska, Magdalena |
|
|
224 |
C |
p. |
artikel |
8 |
The combination of pleconaril, rupintrivir, and remdesivir efficiently inhibits enterovirus infections in vitro, delaying the development of drug-resistant virus variants
|
Ianevski, Aleksandr |
|
|
224 |
C |
p. |
artikel |
9 |
The α-dystroglycan N-terminus is a broad-spectrum antiviral agent against SARS-CoV-2 and enveloped viruses
|
Bigotti, Maria Giulia |
|
|
224 |
C |
p. |
artikel |
10 |
Virological and clinical outcomes in outpatients treated with baloxavir or neuraminidase inhibitors for A(H3N2) influenza: A multicenter study of the 2022–2023 season
|
Goto, Takeyuki |
|
|
224 |
C |
p. |
artikel |